• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Device Problem Material Erosion (1214)
Patient Problems Wound Dehiscence (1154); Hematoma (1884); Seroma (2069); Urinary Tract Infection (2120); Blood Loss (2597); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Date sent to the fda: 08/1/2018.(b)(4).Citation: female pelvic medicine & reconstructive surgery.2012; 18(5).Doi: 10.1097/spv.0b013e3182673772.
 
Event Description
It was reported via journal article: "title: abdominal sacral hysteropexy: a pilot study comparing sacral hysteropexy to sacral colpopexy with hysterectomy" author: kristina cvach, md,* roxana geoffrion, md,þ and geoffrey w.Cundiff, md.Citation: female pelvic medicine & reconstructive surgery.2012; 18(5).Doi: 10.1097/spv.0b013e3182673772.Treatment of pelvic prolapse with uterine conservation using the sacral hysteropexy may be associated with less patient morbidity but has uncertain subjective and objective outcomes.The objectives of this ambispective (retrospective/prospective) study was to compare abdominal sacral hysteropexy (ash) with abdominal sacral colpopexy/total abdominal hysterectomy (asc/tah).A total of 27 patients were eligible for the study including 18 patients who underwent ash (age range: 28 to 71 years old; bmi: 19.71 to 35.27) and 9 subjects who underwent asc/tah (age range: 37 to 66 years old; bmi: 21.09 to 29.30).During the procedure for ash, a 15 × 15 cm piece of large-weave gynecare gynemesh ps mesh (ethicon) is used to fashion two 4.5- to 5-cm-wide strips of mesh; one is bisected for a distance of 5 cm to produce a y-configuration for the anterior mesh.The anterior mesh arms are passed through the broad ligament windows and attached to the cervix and pubocervical fascia using interrupted pds 2-0 sutures (ethicon).The posterior mesh is attached to the distal rectovaginal fascia using transverse-interrupted pds 2-0 sutures.The mesh is attached as far distally as possible to provide maximum support and elevation to the posterior wall and the apical compartment.A halban culdoplasty is performed using pds 2-0 sutures to obliterate the cul-de-sac and prevent entrapment of bowel under the mesh.Once the sacral dissection has exposed the anterior longitudinal ligament and middle sacral vessels, the proximal ends of the 2 mesh strips are attached to the sacral promontory using 2 ethibond 2-0 sutures (ethicon) to provide elevation of the uterus without tension.The peritoneum is closed over the mesh using vicryl 3-0 suture (ethicon).During the procedure for asc/tah, after abdominal hysterectomy with single-layer vault closure using vicryl 2-0 sutures, further dissection of the bladder off the pubocervical fascia is performed.The rectovaginal space is entered as for ash.Two 4.5- to 5-cm-wide strips of gynecare gynemesh ps mesh are attached to the pubocervical and rectovaginal fascia, respectively, using transverse-interrupted pds 2-0 sutures.Halban culdoplasty, sacral dissection, and attachment of the sacral ends of the mesh strips is performed as for ash.Reported complications included urinary tract infection (n-1), ileus (n-2), superficial wound dehiscence (n-1), and seroma (n-1).In the ash group, reported complications included isolated anterior compartment failure (n-8), isolated posterior compartment failure (n-1), failure in both compartments (n-2), and recurrent prolapse (n-1) which required posterior repair with fascial replacement.In the asc/tah group, reported complications included bleeding at rectocele repair (n-1) which required blood transfusion, rectus sheath hematoma (n-1) which required blood transfusion, mesh erosion (n-3) which were managed successfully with surgical excision of the mesh via a vaginal approach (n-2), isolated posterior compartment failure (n-2), failure in both compartments (n-1).It was concluded that ash may reduce the risk of mesh erosion compared to asc/tah.The trade-offs are the potential increased risk of recurrent anterior compartment prolapse.The study has provided valuable data, which have helped us refine the surgical technique and improve preoperative assessment strategies.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key7740165
MDR Text Key115720466
Report Number2210968-2018-74815
Device Sequence Number1
Product Code GAM
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K022269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 07/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received07/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GYNEMESH, PDS II, ETHIBOND SUTURE
Patient Outcome(s) Required Intervention;
-
-